Acupressure in Hospitalized Patients

Stony Brook University200 enrolled

Overview

After written informed consent eligible hospitalized patients will be randomized to one of 3 arms (1:1:1:): control, sham, accupressure (3 points on the hand and wrist three times per day). Quality of recovery and other measures of patient satisfaction will be recorded.

After written informed consent eligible hospitalized patients will be randomized to one of 3 arms (1:1:1:): control (no touch), sham (light touch), acupressure (2 minutes moderate pressure each at PC6, LI4, and HT7 three times per day). Quality of recovery using the validated Quality of Recovery (QOR) 15 score and other measures of patient satisfaction (nausea score, pain score) will be recorded at baseline and after their 6 study sessions.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

200

Conditions

Acupressure

Interventions

shamOTHER

light touch at established points on hand and wrist

controlOTHER

no contact with the subject

acupressureOTHER

moderate pressure at established points on hand and wrist

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. adults 2. patients at Stony Brook hospital 3. expected to be hospitalized for at least 3 days 4. able to sign informed consent and participate in the study Exclusion Criteria: 1. Under 18 years of age 2. Do not have access to the 3 points on the hand and wrist due to skin breakdown, ulcers, cellulitis, broken bone, indwelling catheter within 5 cm radius of the pressure points. 3. Significant dementia or altered mental status that would prevent assessment of the QOR survey 4. Allergic reaction to ink 5. Stroke or other neurologic condition which precludes sensation in both upper extremities. 6. Ongoing use of regional anesthetic technique 7. Pregnancy

Locations (1)

Stony Brook Medicine

Stony Brook, New York, United States

Outcomes

Primary Outcomes

Change in Quality of Recovery score

The validated QOR15 score will be assessed at baseline (Day 0) and after the 6 sessions have been completed (Day 2) and the change in QOR15 (Day 2 minus Day 0) will be calculated.

Time frame: Time Frame: Day 0, Day 2

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.